Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2SAKURAI, Kaori; SCHUBERT, Carsten; KAHNE, Daniel et al.Journal of the American Chemical Society. 2006, Vol 128, Num 34, pp 11000-11001, issn 0002-7863, 2 p.Article

The human MDM-2 oncogene is overexpressed in leukemiasBUESO-RAMOS, C. E; YUN YANG; DELEON, E et al.Blood. 1993, Vol 82, Num 9, pp 2617-2623, issn 0006-4971Article

A single nucleotide polymorphism in the MDM2 gene : From a molecular and cellular explanation to clinical effectBOND, Gareth L; WENWEI HU; LEVINE, Arnold et al.Cancer research (Baltimore). 2005, Vol 65, Num 13, pp 5481-5484, issn 0008-5472, 4 p.Article

MDM2 SNP309 and cancer risk : a combined analysisWILKENING, Stefan; BERMEJO, Justo Lorenzo; HEMMINKI, Kari et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 11, pp 2262-2267, issn 0143-3334, 6 p.Article

hdm2 (mdm2 chez la souris) human double minute 2 : Oncogène = hdm2 (mdm2 in mouse) human double minute 2 : oncogeneBulletin du cancer. 2000, Vol 87, Num 9, pp 619-620, issn 0007-4551Article

Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer TherapyQIN LI; LOZANO, Guillermina.Clinical cancer research (Print). 2013, Vol 19, Num 1, pp 34-41, issn 1078-0432, 8 p.Article

Reversal of P-glycoprotein―Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3MICHAELIS, Martin; ROTHWEILER, Florian; KLASSERT, Denise et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 2, pp 416-421, issn 0008-5472, 6 p.Article

RING domain-mediated interaction is a requirement for MDM2's E3 ligase activityKAWAI, Hidehiko; LOPEZ-PAJARES, Vanessa; KIM, Mihee M et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6026-6030, issn 0008-5472, 5 p.Article

Use of a retroinverso p53 peptide as an inhibitor of MDM2SAKURAI, Kaori; HAK SUK CHUNG; KAHNE, Daniel et al.Journal of the American Chemical Society. 2004, Vol 126, Num 50, pp 16288-16289, issn 0002-7863, 2 p.Article

Differential regulation of estrogen receptor α turnover and transactivation by Mdm2 and stress-inducing agentsDUONG, Vanessa; BOULLE, Nathalie; DAUJAT, Sylvain et al.Cancer research (Baltimore). 2007, Vol 67, Num 11, pp 5513-5521, issn 0008-5472, 9 p.Article

Potentiel thérapeutique de drogues antagonistes de Mdm2 = Therapeutic potential of Mdm2 antagonist drugsJEANTEUR, Philippe.Bulletin du cancer. 2004, Vol 91, Num 5, issn 0007-4551, p. 395Article

DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARFLEE, Casey; SMITH, Brian A; BANDYOPADHYAY, Keya et al.Cancer research (Baltimore). 2005, Vol 65, Num 21, pp 9834-9842, issn 0008-5472, 9 p.Article

Lack of MDM2 amplification in human leukaemiaRIDGE, S. A; DYER, M; GREAVES, M. F et al.British journal of haematology. 1994, Vol 86, Num 2, pp 407-409, issn 0007-1048Article

Physical and functional interaction between wild-type p53 and mdm2 proteinsHAINES, D. S; LANDERS, J. E; ENGLE, L. J et al.Molecular and cellular biology (Print). 1994, Vol 14, Num 2, pp 1171-1178, issn 0270-7306Article

Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasmRUMI, Elisa; CASETTI, Ilaria; PIETRA, Daniela et al.American journal of hematology. 2012, Vol 87, Num 1, pp 129-130, issn 0361-8609, 2 p.Article

A novel oncoprotein Pirh2: rising from the shadow of MDM2ZHIHAO WANG; BO YANG; LANLAN DONG et al.Cancer science. 2011, Vol 102, Num 5, pp 909-917, issn 1347-9032, 9 p.Article

MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motilityPOLANSKI, Radosław; MAGUIRE, Maria; BOYD, Mark T et al.Carcinogenesis (New York. Print). 2011, Vol 32, Num 8, pp 1133-1142, issn 0143-3334, 10 p.Article

Activation of Murine Double Minute 2 by Akt in Mammary Epithelium Delays Mammary Involution and Accelerates Mammary TumorigenesisXIAOYUN CHENG; WEIYA XIA; MULLER, William J et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 19, pp 7684-7689, issn 0008-5472, 6 p.Article

MDM2 : A novel Mineralocorticoid-Responsive gene involved in aldosterone-induced human vascular structural remodelingNAKAMURA, Yasuhiro; SUZUKI, Saya; SASANO, Hironobu et al.The American journal of pathology. 2006, Vol 169, Num 2, pp 362-371, issn 0002-9440, 10 p.Article

MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent mannerBOND, Gareth L; HIRSHFIELD, Kim M; TOPPMEYER, Deborah et al.Cancer research (Baltimore). 2006, Vol 66, Num 10, pp 5104-5110, issn 0008-5472, 7 p.Article

Oncogène : hdm2 (mdm2 chez la souris) : human double minute 2 = Oncogene : hdm2 (mdm2 in mouse) : human double minute 2SOUSSI, T.Bulletin du cancer. 1998, Vol 85, Num 9, issn 0007-4551, p. 737Article

Amplification of a gene encoding a p53-associated protein in human sarcomasOLINER, J. D; KINZLER, K. W; MELTZER, P. S et al.Nature (London). 1992, Vol 358, Num 6381, pp 80-83, issn 0028-0836Article

Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinomaWANG QIAN; LI-FU HU; FU CHEN et al.European journal of cancer. Part B, Oral oncology. 1995, Vol 31, Num 5, pp 328-332, issn 0964-1955Article

MDM2 gene amplification in human breast cancerQUESNEL, B; PREUDHOMME, C; FOURNIER, J et al.European journal of cancer. Part A. 1994, Vol 30, Num 7, pp 982-984Article

Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomasWABER, P. G; JUN CHEN; NISEN, P. D et al.Cancer research (Baltimore). 1993, Vol 53, Num 24, pp 6028-6030, issn 0008-5472Article